category guide

How to Choose Homecare & Personal Medical Devices

April 30, 2026· 10 min read· AI-generated

How to Choose Homecare & Personal Medical Devices

A procurement guide for DME suppliers, home health agencies, hospital discharge planners, and ACOs navigating an increasingly complex market.

What this is and who buys it

Homecare and personal medical devices cover a wide sweep of FDA-regulated equipment designed for use outside professional healthcare facilities — by patients, family members, or non-clinical caregivers managing conditions at home. The category includes respiratory therapy equipment (CPAP, APAP, BiPAP, oxygen concentrators, nebulizers), patient monitoring tools (blood pressure monitors, pulse oximeters, glucose meters, continuous glucose monitors), mobility and support hardware (power and manual wheelchairs, hospital beds, patient lifts), and therapeutic devices such as TENS units, infusion pumps, and negative pressure wound therapy systems [S1].

Buyers span a broad organizational range. Hospital discharge planners sourcing equipment for post-CABG or COPD transitions, home health agencies equipping field nurses with portable diagnostics, DME suppliers managing Medicare billing and patient intake, ACOs running remote patient monitoring (RPM) programs, and ASCs supporting post-operative recovery at home are all regular participants in this market. Self-insured employers and Medicare Advantage plans are increasingly active buyers as RPM reimbursement matures under CPT codes 99453, 99454, and 99457. Each of these buyers has a different risk profile and a different reimbursement dependency, which shapes what "best value" actually means in any given procurement.

The market's growth is structural, not cyclical. The global shift of care delivery from expensive institutional settings to the home is driven by aging demographics, chronic disease prevalence, and payer pressure to reduce avoidable admissions. 2024 segmentation data puts therapeutic devices at roughly 46% of the category by revenue, monitoring devices at 22%, and mobility equipment at 18%, with the elderly representing around 40% of the end-user population and patients with chronic illnesses another 28% [S11]. Those proportions matter when you're building a procurement mix: buying to industry averages without mapping to your actual enrolled population is one of the most common errors in DME fleet planning.

Key decision factors

IEC 60601-1-11 compliance is the single most important electrical safety requirement for this category and the one most frequently mishandled in vendor documentation. The standard mandates that medical electrical equipment intended for the home environment be Class II (double-insulated), because residential electrical grounding is unreliable. Class I (grounded) AC-powered designs are not appropriate for home use. Before purchase, request the manufacturer's full IEC 60601-1-11:2015 (or its U.S. national equivalent, ANSI/AAMI HA60601-1-11) test report, including the named, accredited test laboratory [S4]. The FDA mandated compliance with IEC 60601-1:2005/AMD2:2020 for new submissions as of December 17, 2023 [S5].

Lay-operator usability is a structural design requirement, not a marketing claim. Unlike hospital equipment operated by trained clinicians, homecare devices are routinely used by caregivers with limited medical background and variable health literacy. IEC 60601-1-11 references the usability collateral standard IEC 60601-1-6, and the FDA's Human Factors program expects manufacturers of home-use devices to provide summative usability testing data. Ask vendors for their IEC 62366-1 or HE75 usability files and any FDA human factors validation summaries before accepting a device for a patient-facing program [S3].

Power resilience becomes a life-safety issue for devices that support essential functions. For ventilators, home oxygen concentrators, and infusion pumps, battery runtime under full load should be a specified parameter in your RFP, not an afterthought. Essential performance criteria under IEC 60601-1-11 require that equipment continue operating during outages until an alternative power source can be deployed [S4]. Devices with bidirectional communication that can signal low battery to a monitoring center add meaningful risk management value.

Connectivity and reimbursement coding are increasingly intertwined. Verify Bluetooth or cellular telemetry capability, HL7 FHIR data export for EHR integration, and whether the device's data outputs satisfy CPT 99454 (device supply with daily transmissions) and 99457 (monthly monitoring time) billing requirements. On the reimbursement side, map every SKU to its HCPCS code and confirm the current Medicare fee schedule allowable, applicable modifier requirements (KH/KI/KJ for capped rentals), and whether the item falls in a Competitive Bidding Area — because rates for competitively bid items vary significantly by patient zip code [S6, S13].

Consumables economics routinely dwarf the capital cost of a device over its useful life. For PAP therapy alone, a realistic annual replacement schedule includes masks ($50–$200, replaced every six months), cushions ($20–$60, monthly), standard tubing ($5–$35, quarterly), humidifier chambers ($20–$50, every six months), and filters ($5 or less, monthly). Annual CPAP maintenance and replacement costs range from roughly $220 to $1,600 depending on usage patterns [S9]. For CGMs, sensor costs typically dominate total cost of ownership within 12 months of deployment. Model consumable spend per patient before committing to a device platform — especially if the consumables are proprietary.

What it costs

Homecare device pricing spans four orders of magnitude, and the sticker price rarely reflects total cost of ownership. The categories below reflect typical acquisition costs per unit; actual pricing depends on volume, distribution channel, and whether Medicare/insurance is covering the purchase.

Entry ($20–$500): Digital BP cuffs, pulse oximeters, basic glucometers, manual wheelchairs, walkers, nebulizers, and digital thermometers. Generally purchased in volume by home health agencies and DME suppliers.
Mid ($500–$3,000): CPAP/APAP machines (most fall in the $500–$1,000 range retail), stationary oxygen concentrators, standard hospital beds, standard power wheelchairs, infusion pumps, and CGM starter kits [S9, S10].
Premium ($3,000+): BiPAP/non-invasive ventilators, portable oxygen concentrators with high LPM output, home hemodialysis systems, smart insulin pumps, complex rehab power mobility devices, and home NPWT systems. Prices in this tier are rarely publicly listed and should be verified directly with manufacturers or distributors.

Common use cases

The breadth of this category means procurement decisions are highly context-dependent. A hospital discharge program has different durability and reimbursement requirements than an ASC's post-op loaner fleet.

Hospital-to-home discharge programs (post-CABG, COPD, CHF) requiring respiratory therapy and remote monitoring to reduce 30-day readmissions.
ACO/Medicare Advantage RPM programs managing hypertension, diabetes, and CHF with cellular-connected BP monitors, scales, and CGMs.
Hospice and palliative care providing home oxygen concentrators, adjustable hospital beds, and pain infusion pumps — often under Medicare's hospice benefit rather than DMEPOS fee schedule.
ASC post-operative recovery programs using cold therapy units, continuous passive motion devices, and DVT prophylaxis equipment for orthopedic patients.

Regulatory and compliance

Most homecare devices are FDA Class II requiring 510(k) clearance. Common product codes include BZD (CPAP), DQA (pulse oximeters), DXN (blood pressure monitors), and FRN (infusion pumps). Class III devices — which require Premarket Approval rather than 510(k) — include implantable insulin pumps. Before procurement, verify clearance status in the FDA's 510(k) database, confirm the product's UDI per 21 CFR Part 830, and check for any open recalls or Class I/II safety notices [S1, S2]. The phrase "FDA registered" refers to establishment registration, not device clearance — a distinction that matters when verifying a vendor's compliance claims.

For connected devices transmitting protected health information, HIPAA places Business Associate obligations on the supplier. Require a signed BAA, confirm encryption at rest and in transit, and request FDA premarket cybersecurity documentation consistent with the agency's 2023 Refuse-to-Accept policy, which now requires a Software Bill of Materials (SBOM) and a vulnerability disclosure policy for internet-connected devices. On reimbursement, Medicare covers 80% of the DMEPOS fee schedule allowable with patients responsible for the remaining 20% coinsurance. The 2026 DMEPOS Competitive Bidding Final Rule adds CGMs, insulin pumps, ostomy and urological supplies, and off-the-shelf braces to the next bidding round, with contracts effective no later than January 1, 2028, while legacy categories such as CPAP and home oxygen will not be part of this round — though that exclusion may not be permanent [S6, S7, S8].

Service, training, and total cost of ownership

Setup and patient training are frequently underbudgeted. Respiratory equipment typically requires an in-home setup visit by a respiratory therapist, billed under the HCPCS setup component of E0601. Many homecare devices remain too complex for laypeople to use safely without documented instruction, and lay caregivers who lack training on malfunction responses represent a real liability exposure. Budget for teach-back sessions and health-literacy-appropriate instructions for use — printed and video format — not just a user manual in the box [S3].

Calibration cadences vary significantly by device type. Blood pressure monitors should be recalibrated every two years; pulse oximeters annually or per ISO 80601-2-61; glucose meters per ISO 15197 with daily QC strips; ventilators annually plus filter changes per manufacturer IFU; and oxygen concentrators every 1,000–2,000 operating hours. For durable equipment, annual preventive maintenance contracts typically run 8–15% of acquisition cost. Expected useful lifespans range from two to four years for BP cuffs and glucometers, five years for CPAP/APAP machines (Medicare's reasonable useful lifetime), five to seven years (and up to 20,000 hours) for oxygen concentrators, and eight to ten years for hospital beds. The Philips Respironics recall of 2021 — which affected millions of CPAP and BiPAP devices — is a useful reminder that single-source supply chain dependence in a capital-intensive fleet is a risk worth pricing explicitly.

Red flags to watch for

A device marketed as "510(k) exempt" without a corresponding 21 CFR product code citation deserves scrutiny — verify the exemption in the FDA Product Classification database before accepting the claim at face value. Any electrical homecare device that lacks an IEC 60601-1-11 test report, or carries only the general IEC 60601-1 certification, is not appropriately certified for the home environment and should be rejected on safety grounds. For connected devices, the absence of a published cybersecurity SBOM or patch policy is a significant procurement risk, particularly as CMS enforcement of RPM data integrity increases. Finally, vendors who cannot produce a PDAC coding verification letter or DMEPOS accreditation documentation introduce reimbursement compliance risk that can affect your entire Medicare billing relationship — not just the line item in question.

Questions to ask vendors

Provide the FDA 510(k) number, product code, and clearance date for each SKU, plus documentation of any open recalls or Class I/II safety notices in the past five years.
Provide test reports demonstrating compliance with IEC 60601-1-11:2015, IEC 60601-1-2 (EMC), and IEC 62366-1 (usability), including the name of the accredited test laboratory.
What is the HCPCS code, current Medicare fee schedule allowable, and PDAC coding verification letter? Is this item a capped rental, routinely purchased, or inexpensive/routinely purchased under 42 CFR Part 414?
What is the documented MTBF, expected useful life in operating hours and years, and battery runtime under full load for life-sustaining models?
For connected devices: provide the SBOM, vulnerability disclosure policy, BAA template, encryption standards used, and confirm HL7 FHIR export capability for RPM platform integration.
What is the total cost of ownership over five years, including consumables, calibration, PM, and software subscriptions? Provide a unit-economics model with volume assumptions stated explicitly.

Alternatives

The buy-vs-lease-vs-rent decision looks different depending on payer mix. For Medicare populations, home oxygen and PAP equipment typically follow capped rental schedules (36 months for oxygen, 13 months for PAP, then title transfers to the patient) — so "purchasing" is not always an option in fee-for-service programs [S7]. For commercial or cash-pay populations, outright purchase typically breaks even against rental at 10–12 months of use, while operating leases preserve capital but add roughly 8–12% in financing premium over the term.

New vs. refurbished: Certified pre-owned CPAP machines typically range $200–$900 versus $500–$1,000 for new, with 3–12 month warranties from reputable sellers [S10]. Refurbished equipment is reasonable for short-term or self-pay use but should be avoided for life-sustaining applications unless OEM-certified refurbishment documentation is provided.
In-house biomed vs. service contract: The break-even point for in-house maintenance is roughly 75–100 units of a single model. Below that threshold, OEM service contracts at 8–15% of capital cost annually are typically more economical.
Cellular vs. Bluetooth RPM: Cellular connectivity at $8–$15 per device per month eliminates patient Wi-Fi dependency and consistently improves data capture rates in elderly populations; Bluetooth is cheaper but requires active patient app management.
Consumer-grade wearables vs. prescription devices: OTC wearables with FDA clearances for specific indications (e.g., ECG rhythm detection, SpO2 screening) are not substitutes for IEC 60601-compliant prescription devices and should not be used as primary diagnostic tools in clinical programs.

Sources

Browse vendors in

Homecare & Personal Medical Devices

MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.